STOCK TITAN

10x Genomics Inc - TXG STOCK NEWS

Welcome to our dedicated news page for 10x Genomics (Ticker: TXG), a resource for investors and traders seeking the latest updates and insights on 10x Genomics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 10x Genomics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 10x Genomics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.15%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.22%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
15.66%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.95%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.37%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.5%
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.83%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
10x Genomics Inc

Nasdaq:TXG

TXG Rankings

TXG Stock Data

4.47B
102.65M
2.47%
92.51%
7.2%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
US
Pleasanton

About TXG

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.